Background
Influenza virus is a single-stranded RNA virus, segmented, 70nm in diameter and enveloped. Strains are described by geographic origin, strain number, year of isolation and hemagglutination (H) and neuraminidase (N) antigens.

Source

Immunogen: Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/ New Caledonia/20/99 IVR 116. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.

Product

Formulation: Supplied as a liquid in STE, 0.1% sodium azide, 0.005% merthiolate.

Purification Method: Purified by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain; Purified by ultracentrifugation using 10-40% sucrose gradient.

Purity: 90%

Concentration: See vial for concentration

Applications
Has been tested with anti-influenza A monoclonal antibodies in ELISA. Inactivateed by Thimerosal and beta propiolactone treatment Optimal concentration should be evaluated by serial dilutions.

Functional Analysis: ELISA

Storage
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C

Product Stability: See expiration date on vial

Shipping Conditions: Ship at ambient temperature, freeze upon arrival

Caution
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Exalpha Biologicals accepts no liability for any inaccuracies or omissions in this information.

Safety Datasheet(s) for this product: